Klupa T, Benbenek-Klupa T, Malecki M, Szalecki M, Sieradzki J
Department of Metabolic Diseases, Medical College, Jagiellonian University, Krakow, Poland.
J Int Med Res. 2008 Sep-Oct;36(5):1112-6. doi: 10.1177/147323000803600531.
This observational study assessed metabolic control in young, active professionals with type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) with or without the use of a bolus calculator. Eighteen patients aged 19 - 51 years with diabetes duration of 6 - 22 years were included; eight patients used a bolus calculator and 10 did not. Metabolic control was assessed by glycosylated haemoglobin (Hb(A1c)) measurements and blood glucose profiles. A continuous glucose monitoring system (CGMS) was also used by three patients from each group. Mean Hb(A1c) and fasting blood glucose levels were not significantly different between the two groups, but mean post-prandial blood glucose was significantly lower in bolus calculator users than non-users. The CGMS showed more blood glucose levels within the target range in bolus calculator users than non-users, but statistical significance was not achieved. In conclusion, a bolus calculator may help to improve postprandial blood glucose levels in active professional type 1 diabetes patients treated with CSII, but does not have a major impact on Hb(A1c) levels.
这项观察性研究评估了在接受持续皮下胰岛素输注(CSII)治疗的1型糖尿病年轻活跃专业人士中,使用或不使用大剂量胰岛素计算器时的代谢控制情况。纳入了18名年龄在19至51岁、糖尿病病程为6至22年的患者;其中8名患者使用大剂量胰岛素计算器,10名未使用。通过糖化血红蛋白(Hb(A1c))测量和血糖谱评估代谢控制情况。每组各有3名患者还使用了连续血糖监测系统(CGMS)。两组之间的平均Hb(A1c)和空腹血糖水平无显著差异,但使用大剂量胰岛素计算器的患者餐后平均血糖显著低于未使用者。CGMS显示,使用大剂量胰岛素计算器的患者血糖水平在目标范围内的情况多于未使用者,但未达到统计学显著性。总之,大剂量胰岛素计算器可能有助于改善接受CSII治疗的1型糖尿病活跃专业患者的餐后血糖水平,但对Hb(A1c)水平没有重大影响。